APA (7th ed.) Citation

Laban, S., Steinmeister, L., Gleißner, L., Grob, T. J., Grénman, R., Petersen, C., . . . Kriegs, M. (2013). Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation. Radiotherapy & Oncology, 109(2), 286. https://doi.org/10.1016/j.radonc.2013.07.003

Chicago Style (17th ed.) Citation

Laban, Simon, et al. "Sorafenib Sensitizes Head and Neck Squamous Cell Carcinoma Cells to Ionizing Radiation." Radiotherapy & Oncology 109, no. 2 (2013): 286. https://doi.org/10.1016/j.radonc.2013.07.003.

MLA (9th ed.) Citation

Laban, Simon, et al. "Sorafenib Sensitizes Head and Neck Squamous Cell Carcinoma Cells to Ionizing Radiation." Radiotherapy & Oncology, vol. 109, no. 2, 2013, p. 286, https://doi.org/10.1016/j.radonc.2013.07.003.